Aug 05, 2020

FDA approves drug-coated angioplasty balloon catheter for PAD treatment

The FDA has approved a percutaneous transluminal angioplasty catheter with a drug-coated balloon for the treatment of peripheral artery disease. The Lutonix 035 drug-coated balloon (Lutonix DCB; Lutonix Inc./C.R. Bard) is the first of its kind, and is intended to reopen superficial femoral and popliteal arteries that have become narrowed or blocked due to PAD, according to a press release.

Proceed to the page: http://linkis.com/h84QO

Similar Articles Added Earlier

Similar Articles Added Today

  • This Week’s Top Stories About vitamin c supplement » Trentonosno667

    Miley Cyrus and ideal vitamin c nutritional supplement: 10 Shocking Matters They Have in Common According to scientists, vitamin C is an essential vitamin, which assists the human body to deliver collagen, help it become resilient and guard it through the harmful consequences of UV rays. A vitamin...

  • Annamaria ’s Presentations on authorSTREAM

    After the drug detox is entire, people may very well be needed to undergo a number of treatment plans consisting of the two psychological and social therapy.

  • d0xeglv864 » Schoonheidsinstituut Zoe Beauty

    Horstone Massages Pedicure Verven Wimperextentions One Wimperlifting Ontharingen Dames Ontharingen Heren Abi-Simplex Abi-Complex Anti-Acne Treatment Abi-Complex Plus Abi-Complex Actieve Acti

Most Recent healio.com Articles

  • Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

    BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD are still unclear, according to presenters at the Cardiometabolic Health Congress. A debate between Ph. Gabriel Steg, MD, professor of cardiology at...

  • Apixaban superior to warfarin regardless of renal function in patients with AF

    Renal function status had no effect on the superiority of apixaban in efficacy and safety compared with warfarin in patients with atrial fibrillation, according to data published in JAMA Cardiology. In the ARISTOTLE trial, apixaban (Eliquis, Bristol-Myers Squibb/Pfizer) was associated with reduced...

  • Strict glycemic control did not affect survival after CABG

    There was no difference in survival after CABG between patients who underwent a strict glycemic control strategy compared with those who underwent a liberal strategy, according to recent study data. Researchers assessed long-term survival in patients (mean age, 62.7 years; 16% women) randomly...

Latest Links Processed

0/120